Search ARM

Other Industry Events

IO360° Summit


February 23–26, 2021

Immuno-Oncology 360° reports on the most current data and rapid advancements to help IO stakeholders:

  • Be at the forefront of the most relevant research and developments from key leadership who are at the pulse of cancer immunotherapy
  • Foster collaboration amongst those working in all aspects of cancer immunotherapy together under one roof
  • Partner to expand technology platforms to develop therapeutics at an accelerated rate
  • Receive the latest pre-clinical, translational and clinical data from academia and industry
  • Create and prioritize strategies targeted toward specific tumor types
  • Identify and gain a greater understanding of what assets are available for potential combinations
  • Hear from IO clinical trial leaders as they cover trial design, clinical operations, the latest outcomes and lessons learned
  • Get key investor and analyst evaluations and insights on the IO landscape, challenges and what’s next
  • Learn about biomarker advancements in vaccines, imaging, neoantigen approaches and more
  • Obtain coverage on a wide range of emerging technologies


  • Padmanee Sharma, MD, PhD, MD Anderson Cancer Center
  • Elizabeth Marion Jaffee, PhD, Johns Hopkins University
  • Kole Roybal, PhD, University of California, San Francisco
  • Lisa Butterfield, PhD, Parker Institute for Cancer Immunotherapy
  • Andrew Baum, MD, Citi

Learn more about the upcoming IO360° Summit at

Receive a 10% discount with code ARM10